SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950116-01-501022
Filing Date
2001-10-29
Accepted
2001-10-29 00:00:00
Documents
8
Period of Report
2001-07-31

Document Format Files

Seq Description Document Type Size
1 10-K tenk.txt 10-K 298192
3 EXHIBIT 4.2.3 ex4-2_3.txt EX-4 37297
4 EXHIBIT 10.13 ex10-13.txt EX-10.13 14741
5 EXHIBIT 10.14 ex10-14.txt EX-10.14 21300
6 EXHIBIT 21 ex21.txt EX-21 615
7 EX-23.1.1 ex23-1_1.txt EX-23.1.1 575
8 EX-23.1.2 ex23-1_2.txt EX-23.1.2 667
9 EXHIBIT 24 ex24.txt EX-24 4201
  Complete submission text file 0000950116-01-501022.txt   379388
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-25169 | Film No.: 1768396
SIC: 2834 Pharmaceutical Preparations